gc-1 peptide peptides - GC-1sobetirome results Gc Unveiling the Potential of GC-1 Peptide: A Thyromimetic with Therapeutic Promise

GC-1sobetirome side effects The scientific community has long been intrigued by compounds that can mimic the effects of natural hormones, particularly those involved in metabolic regulation.Sobetirome (GC-1, QRX431) is a potent and selective agonist of thyroid hormone receptor β (TRβ) , with an EC50 of 0.16 μM for TRβ-1. It is used in re. Among these, the GC-1 peptide, also known as Sobetirome, has emerged as a significant area of research. This synthetic thyromimetic compound exhibits a unique ability to selectively target and activate thyroid hormone receptors, opening doors to potential therapeutic applications in metabolic disordersDiscoverGc-1sobetirome 1500 mcg, a premiumPeptidesfor your daily routine. Available now at Biolab Shop..

At its core, GC-1 functions as a selective agonist for the thyroid hormone receptor beta (TRβ). This means it binds preferentially to the TRβ1 subtype, exhibiting a higher affinity compared to the TRα1 receptor. Research has demonstrated that GC-1 binds to TRβ1 with an EC50 of 0.16 μM and to TRα1 with a KD value of 440 pM, while showing a KD of 67 pM for hTRβ1. This selectivity is crucial, as it allows for the modulation of thyroid hormone signaling pathways without the broad systemic effects often associated with natural thyroid hormones. The peptide nature of GC-1 contributes to its specific biological interactions.

The therapeutic implications of GC-1 peptide are primarily linked to its metabolic effects. Studies have shown that GC-1 can significantly increase metabolic rate, effectively converting "bad" white fat, which stores excess calories and is associated with obesity, into "good" brown fat. This process enhances calorie expenditure and can lead to a reduction in fat mass. In rodent models, GC-1 has been observed to prevent steatosis (fatty liver) and induce a marked reduction of pre-accumulated fat without causing significant side effects on heart rate. This is a critical distinction, as traditional thyroid hormone therapies can lead to tachycardia and other cardiovascular issues.

Furthermore, research has explored the impact of GC-1 on lipid and bile acid metabolism. It has been shown to influence these pathways, potentially offering benefits for conditions like dyslipidemiaFormylPeptideReceptor (FPR) · Melanocortin Receptor · GRK · G Protein · Platelet ...GC-1, QRX-431. Storage. Store lyophilized at -20ºC, keep desiccated. In .... The compound has also demonstrated the ability to lower cholesterol with significantly higher potency and efficacy compared to other agents. This multifaceted action on metabolic processes underscores the potential of GC-1 as a therapeutic agent for conditions such as obesity and the metabolic syndrome. Beyond its metabolic roles, GC-1 has also been investigated for its effects on different liver disorders, suggesting a broader clinical applicability作者：GJ Grover·2004·被引用次数：199—For these studies, the TRβ selective agonist,GC-1, was used to assess selectivity for lipid-lowering and metabolic rate changes relative to tachycardia..

The scientific exploration of GC-1 peptide is ongoing, with a focus on understanding its precise mechanisms of action and optimizing its therapeutic potential. Ongoing research aims to demonstrate TH-selective signaling effects on reproductive and lactational performance in hypothyroid rats, further expanding our understanding of its biological impact. The development of improved synthesis methods for GC-1 is also a key area of focus, ensuring the availability of this promising compound for further study and potential clinical use. While the term GC might refer to various entities, in this context, it specifically points to the thyromimetic GC-1Sobetirome (GC-1; QRX-431) | CAS 211110-63-3. The emergence of Peptides like GC-1 signifies a growing interest in targeted molecular interventions for complex health conditions. The availability of Gc-1 sobetirome in various forms, including at 1500 mcg, indicates its progression from a research compound to a product accessible for specialized applications. The exploration of GC-1 peptide benefits and potential GC-1sobetirome side effects remains a vital part of its scientific narrative, ensuring its safe and effective application. The compound's ability to act as a thyroid hormone receptor agonist, specifically targeting TRβ, is central to its therapeutic promise. The scientific community continues to investigate GC 1 and its various derivatives, with a particular interest in its role as a peptide in metabolic regulation.